These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28528766)

  • 1. When zoster hits close to home: Impact of personal zoster awareness on zoster vaccine uptake in the U.S.
    Harpaz R; Leung J
    Vaccine; 2017 Jun; 35(27):3457-3460. PubMed ID: 28528766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
    Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
    Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
    Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
    Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Pharmacist Interventions on Herpes Zoster Vaccination Rates.
    Eid DD; Meagher RC; Lengel AJ
    Consult Pharm; 2015 Aug; 30(8):459-62. PubMed ID: 26260642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of shingles vaccine acceptance in the United Kingdom.
    Bricout H; Torcel-Pagnon L; Lecomte C; Almas MF; Matthews I; Lu X; Wheelock A; Sevdalis N
    PLoS One; 2019; 14(8):e0220230. PubMed ID: 31369608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.
    Valente N; Lupi S; Stefanati A; Cova M; Sulcaj N; Piccinni L; ; Gabutti G
    BMJ Open; 2016 Oct; 6(10):e011539. PubMed ID: 27797989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008.
    Lu PJ; Euler GL; Harpaz R
    Am J Prev Med; 2011 Feb; 40(2):e1-6. PubMed ID: 21238856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoster vaccine in older adults.
    Fried R
    J Am Geriatr Soc; 2010 Sep; 58(9):1799-800. PubMed ID: 20863342
    [No Abstract]   [Full Text] [Related]  

  • 11. [Shingles vaccine: which recommendations in 2014?].
    Vionnet J; Hart K; Spertini F
    Rev Med Suisse; 2014 Apr; 10(426):869-72, 874-5. PubMed ID: 24834646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming barriers to adult immunization.
    High KP
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S25-8. PubMed ID: 19553634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
    Draper M; Stergiopoulos S
    Vaccine; 2021 Nov; 39(46):6781-6786. PubMed ID: 34625290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Physician Attitudes and Practices Regarding Herpes Zoster Vaccination.
    Tsui E; Gillespie C; Perskin M; Zabar S; Wu M; Cohen EJ
    Cornea; 2018 Aug; 37(8):947-951. PubMed ID: 29578865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary care physicians' experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV).
    Hurley LP; Allison MA; Dooling KL; O'Leary ST; Crane LA; Brtnikova M; Beaty BL; Allen JA; Guo A; Lindley MC; Kempe A
    Vaccine; 2018 Nov; 36(48):7408-7414. PubMed ID: 30420121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease.
    Tseng HF; Smith N; Harpaz R; Bialek SR; Sy LS; Jacobsen SJ
    JAMA; 2011 Jan; 305(2):160-6. PubMed ID: 21224457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
    de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
    Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving rates of herpes zoster vaccination with a clinical decision support system in a primary care practice.
    Chaudhry R; Schietel SM; North F; Dejesus R; Kesman RL; Stroebel RJ
    J Eval Clin Pract; 2013 Apr; 19(2):263-6. PubMed ID: 22304668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination.
    Elkin Z; Cohen EJ; Goldberg JD; Gillespie C; Li X; Jung J; Cohen M; Park L; Perskin MH
    Cornea; 2013 Jul; 32(7):976-81. PubMed ID: 23449488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.